Tubulis today announced the appointment of Charles Fuchs, MD, as Chief Medical Officer (CMO). Dr. Fuchs is an internationally ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

While observing the rapid evolution of medical tourism, the Liv model warrants a closer look. It offers a useful reference ...

Liv Hospital, the pioneer provider of personalized care, relies on the principle that each patient's cancer is different. The team undertakes to target the specific causes of a person's cancer rather ...

People with cancer may receive treatment from a medical oncologist, who uses chemotherapy, targeted or biologic therapies, hormonal therapies, or other chemical agents to cure, stop, or slow the ...

The merger enhances Verana Health's data capabilities across oncology, ophthalmology, urology, and neurology, supporting clinical research and regulatory decision-making. Integration of COTA's ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

The SSM Health/Saint Louis University Division of Hematology and Medical Oncology offers a three-year subspecialty residency that places an emphasis on inpatient and outpatient care, as well as ...

Patients with advanced epithelial ovarian cancer generally require postoperative platinum-based chemotherapy in an attempt to prolong both disease-free and overall survival. Unlike most other areas of ...

David M. Aboulafia, M.D.: AIDS-related cancers, leukemia and lymphoma, myeloproliferative disorders, multiple myeloma; Virginia Mason Seattle Medical Center, Hematology/Oncology, 1100 Ninth Ave., ...